- Report
- October 2024
- 189 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- February 2025
- 167 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- July 2022
- 193 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- January 2022
- 117 Pages
Global
From €4533EUR$4,750USD£3,798GBP
The Human Reproductive Technologies market is a subset of the Sexual and Reproductive Health Drugs market. It includes products and services related to fertility, contraception, and assisted reproductive technologies. These technologies are used to help individuals and couples conceive, prevent pregnancy, and manage reproductive health. They include fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and ovulation induction, as well as contraception methods such as birth control pills, intrauterine devices (IUDs), and male and female condoms. Assisted reproductive technologies include egg and sperm donation, surrogacy, and preimplantation genetic diagnosis (PGD).
Some companies in the Human Reproductive Technologies market include Ferring Pharmaceuticals, Merck, Bayer, and CooperSurgical. Show Less Read more